Systemic lupus erythematosus : Focus on new advances / Nabil Mohamed Hassan Al-Ashmory ; Supervised Zeinab Osman Nawito , Samar Mohamed Fawzy Ahmed

By:

Nabil Mohamed Hassan Al-Ashmory

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Nabil Mohamed Hassan Al-Ashmory , 2013Description: 140 P. : facsimiles ; 25cmOther title:

الذئبة الحمراء : التركيز على التطورات الجديدة [Added title page title]

Subject(s):

Online resources:

Click here to access online

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation Summary: systemic lupus erythematosus (SLE) is the prototypic autoimmune disease. It is associated with more than 30 genes. The systemic lupus international Collaborating Clinics group revised and validated the American College of Rheumatology classification criteria in 2012. Recent randomized clinical trials for new biologic treatment used a new composite assessment, called SLE Responder Index, as its primary outcome.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.32.M.Sc.2013.Na.S (Browse shelf(Opens below))		Not for loan	01010110060945000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.32.M.Sc.2013.Na.S (Browse shelf(Opens below))	60945.CD	Not for loan	01020110060945000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation

systemic lupus erythematosus (SLE) is the prototypic autoimmune disease. It is associated with more than 30 genes. The systemic lupus international Collaborating Clinics group revised and validated the American College of Rheumatology classification criteria in 2012. Recent randomized clinical trials for new biologic treatment used a new composite assessment, called SLE Responder Index, as its primary outcome.

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer